PBSV — Stock Film
STOCK FILMSCENE 1/11PBSV · $0.58
Stock Expert AI presents
PBSV
Pharma-Bio Serv, Inc
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Pharma-Bio Serv, Inc. A quick introduction.

On the stock market since 2007, it operates in the world of heavy industry. It has 55 employees. Now — the numbers.

on the stock market since 2007
55 employees
$13.3M market value
Revenue last year:
$0
The loss that same year:
$0
Sales don’t cover the costs; the gap drains from the cash pile every year.

The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.

THE SALES TREND
Sales have been shrinking.

An average decline of 18% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.

$20.1M
2021
$19.4M
2022
$17M
2023
$9.5M
2024
$9M
2025
In the vault right now:
$0
DEBT: $29K
At this pace, that money lasts about 108 years.

Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.

Every quarter, analysts set a profit bar.
How many of the last 8 did the company clear?
1 / 8
EXPECTATIONS MET OR BEATEN
1
Sep 2024
Jan 2025
Mar 2025
Jun 2025
Sep 2025
Jan 2026
Mar 2026
Jun 2026
1 TIME IN THE LAST 8 QUARTERS
It misses the bar more often than not.
What executives did with their own stock over the last 12 months:
33 buy37 sell

Executive selling isn’t always bad news; people sell for personal reasons too. Still, the thin buying side is worth noting.

THE FIVE-YEAR JOURNEY
Below the peak, but no collapse.

The stock trades 52% below its peak. The market has trimmed its expectations for the company.

1
THE BRIGHT SIDE · 1/2
Strong cash, light debt

There is $10.9M in the vault; even if every debt were paid off, $10.8M would remain.

2
THE BRIGHT SIDE · 2/2
Pays a steady dividend

It pays out $0.08 per share each year — regular cash for whoever holds the stock.

1
THE RISKS · 1/2
Small scale, thin loss

A loss of $100K against $9.0M in annual sales. And on top of that, sales fell from the year before.

2
THE RISKS · 2/2
Trading under $1

The stock sits at $0.58. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.

FINALE · THE GRADE
D
0 / 100 · MoonshotScore

On our five-subject report card, PBSV sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: PBSV is a small company that closed last year at a loss. The road back to profit runs through spending discipline.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 24, 2026 · stockexpertai.com · Stock Film